MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1164/rccm.200608-1109oc

Медицинская библиотека · American journal of respiratory and critical care medicine · 2006

Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens.

Chee Cynthia B E, KhinMar Kyi W, Gan Suay H, Barkham Timothy M S, Pushparani Mariappan, Wang Yee T

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

RATIONALE: There is currently no available test for monitoring the effect of treatment of latent tuberculosis infection (LTBI) to indicate cure or predict risk of subsequent progression to disease.

OBJECTIVE

We used the T-SPOT.TB assay, which measures T-cell interferon-gamma responses to the Mycobacterium tuberculosis-specific peptides early secretory antigenic target 6-kD protein (ESAT-6) and culture filtrate protein 10 (CFP-10), to determine the effect of LTBI treatment on these responses.

METHODS

A total of 226 tuberculosis contacts with positive T-SPOT.TB results underwent repeat testing on LTBI treatment completion. The majority (96%) received 6 months of isoniazid. The pre- and post-treatment T-SPOT.TB results were analyzed according to the combined and separate responses to ESAT-6 and CFP-10 antigens.

RESULTS

The T-SPOT.TB reverted to negative in 85 (37.6%) contacts at treatment completion. Treatment had a significant effect on the response to CFP-10 (p < 0.001; reversion rate, 48.6%), but not on the response to ESAT-6 (p = 0.081; reversion rate, 21.6%). The median number of spot-forming cells (SFCs)/2.5 x 10(5) peripheral blood mononuclear cells (PBMCs) pre- and post-treatment was 6 versus 4.5 for ESAT-6 (p = 0.116) and 11 versus 4 for CFP-10 (p < 0.001). There was a significant difference between the change (fall) in the pre- and post-treatment responses to CFP-10 (6 SFCs/2.5 x 10(5) PBMCs) and ESAT-6 (0 SFCs/2.5 x 10(5) PBMCs; p < 0.001). Significantly different age-related T-cell responses to the two antigens were found.

CONCLUSION

LTBI treatment had a differential effect on T-cell responses to ESAT-6 and CFP-10 as measured by the T-SPOT.TB. The quantitative response to CFP-10 may be a useful LTBI treatment-monitoring tool.

Для цитирования: Chee Cynthia B E, KhinMar Kyi W, Gan Suay H, Barkham Timothy M S, Pushparani Mariappan, Wang Yee T. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens.. American journal of respiratory and critical care medicine. 2006. DOI: 10.1164/rccm.200608-1109oc.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.